Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Electric cars, climate credit schemes, diverse boardrooms and legal weed: How California exports its ideas and policies across the U.S. Bondi’s testimony on the Epstein files was mostly punctuated by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results